Zhaokang Cheng

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Topics

Endoplasmic Reticulum Stress

Top Venues

Cardiovascular research

The Journal of biological chemistry

Physiological reports

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Jingrui Chen, Jing Wei, Peng Xia, Yuening Liu, Mahder Dawit Belew, Ryan Toohill, Boyang Jason Wu, Zhaokang Cheng
Inhibition of CDK7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy. Cardiovascular research (2024)
Jingrui Chen, Jing Wei, Peng Xia, Yuening Liu, Mahder Dawit Belew, Ryan Toohill, Boyang Jason Wu, Zhaokang Cheng
Inhibition of CDK7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy. Cardiovascular research (2024)
Phichaya Suthivanich, Worakan Boonhoh, Natticha Sumneang, Chuchard Punsawad, Zhaokang Cheng, Sukanya Phungphong
Aerobic Exercise Attenuates Doxorubicin-Induced Cardiomyopathy by Suppressing NLRP3 Inflammasome Activation in a Rat Model. International journal of molecular sciences 25 (17) (2024)
Jingrui Chen, Jing Wei, Peng Xia, Yuening Liu, Mahder Dawit Belew, Ryan Toohill, Boyang Jason Wu, Zhaokang Cheng
Inhibition of cyclin-dependent kinase 7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy. Cardiovascular research 120 (9) (2024)
Jingrui Chen, Jing Wei, Peng Xia, Yuening Liu, Mahder Dawit Belew, Ryan Toohill, Boyang Jason Wu, Zhaokang Cheng
Inhibition of cyclin-dependent kinase 7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy. Cardiovascular research 120 (9) (2024)
Jingrui Chen, Jing Wei, Peng Xia, Yuening Liu, Mahder Dawit Belew, Ryan Toohill, Boyang Jason Wu, Zhaokang Cheng
Inhibition of CDK7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy. Cardiovascular research (2024)
Jingrui Chen, Peng Xia, Yuening Liu, Clark Kogan, Zhaokang Cheng
Loss of Rbl2 (Retinoblastoma-Like 2) Exacerbates Myocardial Ischemia/Reperfusion Injury. Journal of the American Heart Association 11 (19) (2022)
Yuening Liu, Peng Xia, Jingrui Chen, W Patricia Bandettini, Lawrence S Kirschner, Constantine A Stratakis, Zhaokang Cheng
PRKAR1A deficiency impedes hypertrophy and reduces heart size. Physiological reports 8 (6) (2021)
Peng Xia, Yuening Liu, Jingrui Chen, Shelby Coates, David X Liu, Zhaokang Cheng
Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy. The Journal of biological chemistry 293 (51) (2018)
Peng Xia, Yuening Liu, Zhaokang Cheng
Signaling Pathways in Cardiac Myocyte Apoptosis. BioMed research international 2016 (2016)